drugset / Trial / NCT02456558
Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will evaluate the safety, tolerability, antiretroviral activity, pharmacokinetics, and pharmacodynamics of an intravenous formulation of deferiprone in HIV-infected subjects.
Timeline
- Start
- 2015-06
- Primary completion
- 2016-03
- Completion
- 2016-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Deferiprone | Small molecule | 1.5 g | Intravenous |
| Subject | Deferiprone | Small molecule | 2 g | Intravenous |
Indications
No indication recorded.